Response to Michael

American Journal of Gastroenterology

Volumn 107, Issue 6, 2012, Pages 950-951

  Rizvi, Sumera ^a   Schoen, Robert E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON;

DRUG COST; DRUG WITHDRAWAL; ENTERITIS; EVIDENCE BASED MEDICINE; HUMAN; LETTER; LOW DRUG DOSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC ERROR;

EID: 84861860107     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.96     Document Type: Letter

References (6)

1. Gasche C, Berstad A, Befrits R et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13: 1545-53.
2. Kulnigg S, Stoinov S, Simanenkov V e t al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008; 103: 1182-92. (Pubitemid 351677967)
3. Schroder O, Mickisch O, Seidler U et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron defi ciency anemia in patients with inflammatory bowel disease-a randomized, controlled, openlabel, multicenter study. Am J Gastroenterol 2005; 100: 2503-9.
4. Lindgren S, Wikman O, Befrits R et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009; 44: 838-45.
5. Michael A. Oral vs. IV iron in inflammatory bowel disease. Am J Gastroenterol 2012, this issue.
6. Rizvi S, Schoen RE. Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap? Am J Gastroenterol 2011; 106: 1872-9.